Open access
Open access
Powered by Google Translator Translator

Endocrinology

International Consensus on the Diagnosis and Management of Dumping Syndrome

29 May, 2020 | 03:12h | UTC

International consensus on the diagnosis and management of dumping syndrome – Nature Reviews Endocrinology

 

Short Review: Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020

27 May, 2020 | 02:18h | UTC

Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020 – JAMA (free for a limited period)

 

Study: Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients

26 May, 2020 | 09:43h | UTC

Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – the “Gabrin sign” – Journal of the American Academy of Dermatology

 

Systematic Review Shows Evidence is Inconclusive on the Use of Non‐nutritive Sweeteners for Diabetes Mellitus

26 May, 2020 | 09:27h | UTC

Non‐nutritive sweeteners for diabetes mellitus – Cochrane Library

Summary: Non-nutritive sweeteners for diabetes mellitus – Cochrane Library

 

Meta-Analysis: Progression to Type 2 Diabetes in Women with Previous Gestational Diabetes

14 May, 2020 | 02:11h | UTC

Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis – The BMJ

Commentary: Gestational diabetes—missed opportunities in post-partum follow-up – The BMJ Opinion

 

Comparison Approaches to Lipid Management: AHA/ACC vs. ESC/EAS Guidelines

12 May, 2020 | 03:07h | UTC

Comparison of Transatlantic Approaches to Lipid Management: The AHA/ACC/Multisociety Guidelines vs the ESC/EAS Guidelines – Mayo Clinic Proceedings

 

Cohort Study: SLGT2 Inhibitors Linked to Lower Risk of Renal Events in Patients with Type 2 Diabetes

7 May, 2020 | 08:57h | UTC

Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study – The BMJ

Editorial: SGLT2 inhibitors and kidney outcomes in the real world

Commentary: Certain diabetes drugs may protect against serious kidney problems – The BMJ

Related Analysis: Communicating emerging risks of SGLT2 inhibitors—timeliness and transparency of medicine regulators – The BMJ

 

Obesity Could Shift Severe COVID-19 Disease to Younger Ages

5 May, 2020 | 04:53h | UTC

Obesity could shift severe COVID-19 disease to younger ages – The Lancet

 

 

[Abstract Only] Randomized Trial: No Benefit from L-thyroxine Among Elderly Patients with Symptomatic Subclinical Hypothyroidism

5 May, 2020 | 04:11h | UTC

L-Thyroxine Therapy for Older Adults With Subclinical Hypothyroidism and Hypothyroid Symptoms: Secondary Analysis of a Randomized Trial – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentaries: L-thyroxine did not improve symptoms or tiredness in older patients with subclinical hypothyroidism – ACP Internist AND More Evidence Against L-Thyroxine for Subclinical Hypothyroidism – NEJM Journal Watch

Related Articles: Association Between Levothyroxine Treatment and Thyroid-Related Symptoms Among Adults Aged 80 Years and Older With Subclinical Hypothyroidism – JAMA AND Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism – New England Journal of Medicine

 

Obesity and Impaired Metabolic Health in Patients with COVID-19

26 Apr, 2020 | 21:25h | UTC

Obesity and impaired metabolic health in patients with COVID-19 – Nature Reviews Endocrinology

 

Practical Recommendations for the Management of Diabetes in Patients with COVID-19

26 Apr, 2020 | 21:24h | UTC

Practical recommendations for the management of diabetes in patients with COVID-19 – The Lancet Diabetes & Endocrinology

 

Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths

23 Apr, 2020 | 09:27h | UTC

Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: modelling study – The BMJ

Commentaries: Salt substitution could prevent almost half a million deaths from CVD in China – George Institute for Global Health AND Embracing salt substitutes could help China prevent 450K CVD deaths per year – Cardiovascular Business

 

Endocrinology in the Time of COVID-19: Management of Adrenal Insufficiency

22 Apr, 2020 | 08:52h | UTC

Endocrinology in the time of COVID-19: Management of adrenal insufficiency – European Journal of Endocrinology

 

Podcast: Hypothyroidism Master Class

21 Apr, 2020 | 07:56h | UTC

#208 Hypothyroidism Master Class with Susan Mandel MD, MPH – The Curbsiders Internal Medicine Podcast

 

Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-income Countries

21 Apr, 2020 | 07:53h | UTC

Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 – Nature Medicine

 

Study: HDL-C is Associated with Mortality from All Causes, Cardiovascular Disease and Cancer in a J-shaped Dose-response Fashion

17 Apr, 2020 | 01:55h | UTC

HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies – European Journal of Preventive Cardiology

 

AHA Statement: Management of Stable Coronary Artery Disease in Patients with Type 2 Diabetes

14 Apr, 2020 | 02:33h | UTC

Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association – Circulation

News Release: People with type 2 diabetes and heart disease may benefit from newer therapies – American Heart Association

 

Studies: Obesity Increases the Risk of Complications in Patients with Covid-19

13 Apr, 2020 | 00:14h | UTC

1 – High prevalence of obesity in severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) requiring invasive mechanical ventilation – Obesity

2 – Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission – Clinical Infectious Diseases AND Commentary: In New York, obesity appears to raise COVID-19 risk – CIDRAP

 

Studies: Diabetes Increases the Risk of Complications in Patients with Covid-19

13 Apr, 2020 | 00:12h | UTC

1 – Prevalence and impact of diabetes among people infected with SARS-CoV-2 – Journal of Endocrinological Investigation AND Commentary: Diabetes Could Increase Severity of COVID-19, Including Risk of ICU Admission and Death – MedicalResearch.com

2 – Evidence Reviews: Diabetes and risks from COVID-19 – CEBM University of Oxford AND Managing diabetes during the COVID-19 pandemic – CEBM University of Oxford

 

Meta-Analysis: Comparative Weight Loss with Popular Diets

3 Apr, 2020 | 03:50h | UTC

Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials – The BMJ

Editorial: Comparative weight loss with popular diets

Commentary: Most Diets Lead to Weight Loss and Lower Blood Pressure, but Effects Largely Disappear After a Year: Study – MDIndia

 

[Abstract Only] A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity

1 Apr, 2020 | 05:39h | UTC

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity – New England Journal of Medicine (link to abstract – $ for full-text)

 

#ACC20 – Randomized Trial: Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

30 Mar, 2020 | 01:03h | UTC

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes – JAMA

See also: Visual Abstract

Just Presented at the 2020 American College of Cardiology Virtual Meeting (free access)

 

Randomized Trial: Aspirin Not Beneficial for Reducing the Risk of Dementia, MCI, or Cognitive Decline

26 Mar, 2020 | 02:20h | UTC

Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline – Neurology (PDF)

Commentary: Study: An aspirin a day does not keep dementia at bay – American Academy of Neurology (free)

 

Obesity Treatment Among Adolescents: A Review of Current Evidence and Future Directions

24 Mar, 2020 | 11:04h | UTC

Obesity Treatment Among Adolescents: A Review of Current Evidence and Future Directions – JAMA Pediatrics (free for a limited period)

 

FDA: Stop SGLT2 Inhibitors Before Scheduled Surgery

20 Mar, 2020 | 10:52h | UTC

FDA Approves Label Changes to SGLT2 Inhibitors Regarding Temporary Discontinuation of Medication Before Scheduled Surgery – U.S. Food & Drug Administration (free)

Commentary: FDA advises stopping SGLT2 inhibitor treatment prior to surgery – The Hospitalist (free)

“- Canagliflozin, dapagliflozin, and empagliflozin should each be discontinued at least three days before scheduled surgery.

– Ertugliflozin should be discontinued at least four days before scheduled surgery.

– Blood glucose levels should be carefully monitored after discontinuation of the SGLT2 inhibitor and appropriately managed before surgery.”